Valiant Organics Limited has announced a board meeting on November 13, 2024, to discuss several key matters. The board approved the unaudited financial results for the quarter and half-year ended September 30, 2024. The company reported a revenue of ₹32,809.28 Cr for the half-year, reflecting challenges due to low sales volume and operational capacity utilization.
Additionally, there was a proposal to increase the authorized share capital to ₹55 Cr and a rights issue to raise up to ₹50 Cr. The board also approved the issuance of 15,000 employee stock options at an exercise price of ₹10 each, enhancing employee engagement and retention. Overall, these steps indicate the company's focus on strengthening its capital structure and sustaining operations.